Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice. 2019

Yoshitomo Hamano, and Fuyu Ito, and Osamu Suzuki, and Minako Koura, and Shuji Matsuoka, and Toshiyuki Kobayashi, and Yoshinobu Sugitani, and Nadila Wali, and Ai Koyanagi, and Okio Hino, and Shoichi Suzuki, and Ryuichi Sugamata, and Hiromichi Yoshizawa, and Wako Yumura, and Naoki Maruyama, and Yosuke Kameoka, and Yoshihiro Noda, and Yasuko Hasegawa, and Tomio Arai, and Kazuo Suzuki
Department of Pathology and Oncology, Juntendo University School of Medicine, Tokyo, Japan.

Lupus nephritis (LN) is the secondary glomerulonephritis (GN) involved in systemic lupus erythematosus (SLE) and a typical immune complex-type GN. Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is an autoimmune disease characterized by systemic vasculitis and pauci-immune-type crescentic glomerulonephritis (CrGN) with ANCA production. Human AAV causes death due to lung haemorrhage and end-stage renal disease, for which renal replacement therapies are necessary. The SLE/AAV overlap syndrome was recently reported in humans. The spontaneous crescentic glomerulonephritis-forming/Kinjoh (SCG/Kj) mouse is a unique model of human AAV showing production of myeloperoxidase (MPO)-ANCA. We previously discovered seven disease susceptibility quantitative trait loci (QTL) derived from SCG/Kj mice by linkage analysis. To investigate the individual functions of each QTL, and to identify AAV susceptibility genes, we introduced them into a B6/lpr background to establish SCG/Kj interval congenic mice (SICM). B6/lpr.C1 mice, a type of SICM, exhibited the production of autoantibodies, including MPO-ANCA. The GN in B6/lpr.C1 mice was not pauci-immune type: deposition of immunoglobulins and complement components was observed in nephritic glomeruli, similar to that in LN. The incidence of GN in female B6/lpr.C1 mice was 100%. Granulocyte infiltration was also observed in the glomerular tuft and crescents. B6/lpr.C1 mice also displayed vasculitis in multiple organs, most frequently the lung and kidney. Vasculitis was characterized by the infiltration of mononuclear cells to vascular walls followed by granulocyte infiltration, resembling human lupus vasculitis. The incidence of lung vasculitis was over 90% in male and female B6/lpr.C1 mice. Blood MPO-ANCA levels were significantly associated with histopathological disease phenotypes. MPO deposition was observed in nephritic glomeruli, and granulocytes infiltrated into inflamed vessels and glomeruli. These observations suggest that the activation of granulocytes and local MPO release contribute to the pathogenesis of GN and vasculitis. As a monocongenic mouse, B6/lpr.C1 mice show the association between murine chromosome 1 segment and autoimmunity. This strain can be used as a model of the SLE/AAV overlap syndrome, and will be useful for elucidating the mechanism of ANCA generation and the pathogenesis of CrGN and vasculitis, as well as in the search for genetic factors related to AAV.

UI MeSH Term Description Entries
D003433 Crosses, Genetic Deliberate breeding of two different individuals that results in offspring that carry part of the genetic material of each parent. The parent organisms must be genetically compatible and may be from different varieties or closely related species. Cross, Genetic,Genetic Cross,Genetic Crosses
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D056648 Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Group of systemic vasculitis with a strong association with ANCA. The disorders are characterized by necrotizing inflammation of small and medium size vessels, with little or no immune-complex deposits in vessel walls. ANCA-Associated Vasculitides,ANCA-Associated Vasculitis,Pauci-Immune Vasculitis,ANCA Associated Vasculitides,ANCA Associated Vasculitis,ANCA-Associated Vasculitide,Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis,Pauci Immune Vasculitis,Pauci-Immune Vasculitides,Vasculitide, ANCA-Associated,Vasculitides, ANCA-Associated,Vasculitides, Pauci-Immune,Vasculitis, ANCA-Associated,Vasculitis, Pauci-Immune

Related Publications

Yoshitomo Hamano, and Fuyu Ito, and Osamu Suzuki, and Minako Koura, and Shuji Matsuoka, and Toshiyuki Kobayashi, and Yoshinobu Sugitani, and Nadila Wali, and Ai Koyanagi, and Okio Hino, and Shoichi Suzuki, and Ryuichi Sugamata, and Hiromichi Yoshizawa, and Wako Yumura, and Naoki Maruyama, and Yosuke Kameoka, and Yoshihiro Noda, and Yasuko Hasegawa, and Tomio Arai, and Kazuo Suzuki
July 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Yoshitomo Hamano, and Fuyu Ito, and Osamu Suzuki, and Minako Koura, and Shuji Matsuoka, and Toshiyuki Kobayashi, and Yoshinobu Sugitani, and Nadila Wali, and Ai Koyanagi, and Okio Hino, and Shoichi Suzuki, and Ryuichi Sugamata, and Hiromichi Yoshizawa, and Wako Yumura, and Naoki Maruyama, and Yosuke Kameoka, and Yoshihiro Noda, and Yasuko Hasegawa, and Tomio Arai, and Kazuo Suzuki
July 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Yoshitomo Hamano, and Fuyu Ito, and Osamu Suzuki, and Minako Koura, and Shuji Matsuoka, and Toshiyuki Kobayashi, and Yoshinobu Sugitani, and Nadila Wali, and Ai Koyanagi, and Okio Hino, and Shoichi Suzuki, and Ryuichi Sugamata, and Hiromichi Yoshizawa, and Wako Yumura, and Naoki Maruyama, and Yosuke Kameoka, and Yoshihiro Noda, and Yasuko Hasegawa, and Tomio Arai, and Kazuo Suzuki
July 2010, Rheumatology (Oxford, England),
Yoshitomo Hamano, and Fuyu Ito, and Osamu Suzuki, and Minako Koura, and Shuji Matsuoka, and Toshiyuki Kobayashi, and Yoshinobu Sugitani, and Nadila Wali, and Ai Koyanagi, and Okio Hino, and Shoichi Suzuki, and Ryuichi Sugamata, and Hiromichi Yoshizawa, and Wako Yumura, and Naoki Maruyama, and Yosuke Kameoka, and Yoshihiro Noda, and Yasuko Hasegawa, and Tomio Arai, and Kazuo Suzuki
July 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Yoshitomo Hamano, and Fuyu Ito, and Osamu Suzuki, and Minako Koura, and Shuji Matsuoka, and Toshiyuki Kobayashi, and Yoshinobu Sugitani, and Nadila Wali, and Ai Koyanagi, and Okio Hino, and Shoichi Suzuki, and Ryuichi Sugamata, and Hiromichi Yoshizawa, and Wako Yumura, and Naoki Maruyama, and Yosuke Kameoka, and Yoshihiro Noda, and Yasuko Hasegawa, and Tomio Arai, and Kazuo Suzuki
July 2003, Kidney international,
Yoshitomo Hamano, and Fuyu Ito, and Osamu Suzuki, and Minako Koura, and Shuji Matsuoka, and Toshiyuki Kobayashi, and Yoshinobu Sugitani, and Nadila Wali, and Ai Koyanagi, and Okio Hino, and Shoichi Suzuki, and Ryuichi Sugamata, and Hiromichi Yoshizawa, and Wako Yumura, and Naoki Maruyama, and Yosuke Kameoka, and Yoshihiro Noda, and Yasuko Hasegawa, and Tomio Arai, and Kazuo Suzuki
July 2014, Clinical and experimental immunology,
Yoshitomo Hamano, and Fuyu Ito, and Osamu Suzuki, and Minako Koura, and Shuji Matsuoka, and Toshiyuki Kobayashi, and Yoshinobu Sugitani, and Nadila Wali, and Ai Koyanagi, and Okio Hino, and Shoichi Suzuki, and Ryuichi Sugamata, and Hiromichi Yoshizawa, and Wako Yumura, and Naoki Maruyama, and Yosuke Kameoka, and Yoshihiro Noda, and Yasuko Hasegawa, and Tomio Arai, and Kazuo Suzuki
September 2008, International immunopharmacology,
Yoshitomo Hamano, and Fuyu Ito, and Osamu Suzuki, and Minako Koura, and Shuji Matsuoka, and Toshiyuki Kobayashi, and Yoshinobu Sugitani, and Nadila Wali, and Ai Koyanagi, and Okio Hino, and Shoichi Suzuki, and Ryuichi Sugamata, and Hiromichi Yoshizawa, and Wako Yumura, and Naoki Maruyama, and Yosuke Kameoka, and Yoshihiro Noda, and Yasuko Hasegawa, and Tomio Arai, and Kazuo Suzuki
January 2015, BioMed research international,
Yoshitomo Hamano, and Fuyu Ito, and Osamu Suzuki, and Minako Koura, and Shuji Matsuoka, and Toshiyuki Kobayashi, and Yoshinobu Sugitani, and Nadila Wali, and Ai Koyanagi, and Okio Hino, and Shoichi Suzuki, and Ryuichi Sugamata, and Hiromichi Yoshizawa, and Wako Yumura, and Naoki Maruyama, and Yosuke Kameoka, and Yoshihiro Noda, and Yasuko Hasegawa, and Tomio Arai, and Kazuo Suzuki
July 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Yoshitomo Hamano, and Fuyu Ito, and Osamu Suzuki, and Minako Koura, and Shuji Matsuoka, and Toshiyuki Kobayashi, and Yoshinobu Sugitani, and Nadila Wali, and Ai Koyanagi, and Okio Hino, and Shoichi Suzuki, and Ryuichi Sugamata, and Hiromichi Yoshizawa, and Wako Yumura, and Naoki Maruyama, and Yosuke Kameoka, and Yoshihiro Noda, and Yasuko Hasegawa, and Tomio Arai, and Kazuo Suzuki
January 2017, Case reports in nephrology and dialysis,
Copied contents to your clipboard!